News
A major Swedish study of 247,420 individuals with attention-deficit/hyperactivity disorder (ADHD) has found that medication ...
Imagine your friend hasn't replied to a message in a few hours. Most people might think, "they are probably just busy." ...
Key symptoms of ADHD include: difficulty staying focused and paying attention, difficulty controlling behaviour, and ...
DELAWARE, DE, UNITED STATES, July 4, 2025 /EINPresswire.com/ -- The global Attention Deficit Hyperactivity Disorder (ADHD) market is anticipated to reach USD 18.3 billion by 2025, as a result of ...
Kids younger than 6 years on extended-release stimulants for ADHD may experience higher rates of side effects due to higher plasma exposures.
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
4d
HealthDay on MSNADHD Medications Remain Linked to Lower Risk for Real-World Adverse OutcomesAttention-deficit/hyperactivity disorder (ADHD) medications remain associated with a reduced risk for various real-world ...
The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings about the risk of weight loss ...
A new study found that exposure to misinformation about ADHD on the platform reduced students’ factual knowledge but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results